GL1X · GenesisL1 explorer

UniProt P01854

Ig epsilon chain C region (P01854)

Ig epsilon chain C region (UniProt P01854): 65 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 183 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P01854
Protein
Ig epsilon chain C region
Experimental structures
65
Predicted models
1
Ligands
7
Pockets
183 · 18 records with a druggable one

Structures

66 records of P01854 in the MolNFT archive: 65 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1F6AStructure of the human ige-fc bound to its high affinity receptor fc(epsilon)ri(alpha)x-ray diffractionB, D——
1F6AStructure of the human IgE-Fc bound to its high affinity receptor FC(EPSILON)RI(ALPHA)x-ray diffractionB, D——
1FP5Crystal structure analysis of the human IgE-Fc CEPSILON3-CEPSILON4 fragment.x-ray diffractionA——
1FP5Crystal structure analysis of the human IgE-Fc CEPSILON3- CEPSILON4 fragment.x-ray diffractionA——
1G84The solution structure of the C EPSILON2 domain from IgEsolution nmrA——
1G84The solution structure of the C EPSILON2 domain from IgEsolution nmrA——
2WQRThe high resolution crystal structure of IgE Fcx-ray diffractionA, B——
2WQRThe high resolution crystal structure of IgE Fcx-ray diffractionA, B——
2Y7QThe high-affinity complex between IgE and its receptor Fc epsilon rix-ray diffractionB, D——
2Y7QThe high-affinity complex between IgE and its receptor Fc epsilon rix-ray diffractionB, D——
3H9YCrystal structure of the IgE-Fc3-4 domainsx-ray diffractionA, B, E——
3H9YCrystal structure of the IgE-FC3-4 domainsx-ray diffractionA, B, E——
3H9ZCrystal structure of the IgE-Fc3-4 domainsx-ray diffractionA, B, C, D——
3H9ZCrystal structure of the IgE-FC3-4 domainsx-ray diffractionA, B, C, D——
3HA0Crystal structure of the IgE-Fc3-4 domainsx-ray diffractionA, B, C, D, E, F——
3HA0Crystal structure of the IgE-FC3-4 domainsx-ray diffractionA, B, C, D, E, F——
4EZMCrystal structure of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23x-ray diffractionA, B, C, D, E, F——
4EZMCrystal structure of the human IgE-FC(EPSILON)3-4 bound to its B cell receptor DERCD23x-ray diffractionA, B, C, D, E, F——
4GKOCrystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor…x-ray diffractionA, B, C, D, E, F——
4GKOCrystal structure of the CALCIUM2+-bound human IgE-FC(EPSILON)3-4 bound to its B cell receptor…x-ray diffractionA, B, C, D, E, F——
4GRGCrystal structure of IgE complexed with E2_79, an anti-IgE inhibitorx-ray diffractionC, D——
4GRGCrystal structure of IgE complexed with E2_79, an anti-IgE inhibitorx-ray diffractionC, D——
4GT7An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, non-receptor binding…x-ray diffractionA, B, C, D——
4GT7An engineered disulfide bond reversibly traps the IgE-FC3-4 in a closed, non-receptor binding…x-ray diffractionA, B, C, D——
4J4PThe complex of human IgE-Fc with two bound Fab fragmentsx-ray diffractionA, B——
4J4PThe complex of human IgE-Fc with two bound Fab fragmentsx-ray diffractionA, B——
4KI1Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor…x-ray diffractionA, B, C, D——
4KI1Primitive triclinic crystal form of the human IgE-FC(EPSILON)3-4 bound to its B cell receptor…x-ray diffractionA, B, C, D——
5ANMCrystal structure of IgE Fc in complex with a neutralizing antibodyx-ray diffractionE, F, GNAG, BMA, MAN11 (best 0.57)
5ANMCrystal structure of IgE Fc in complex with a neutralizing antibodyx-ray diffractionE, F, G——
5HYSStructure of IgE complexed with omalizumabx-ray diffractionG, I, J, KNAG, BMA, MAN, SO412 (best 0.70)
5HYSStructure of IgE complexed with omalizumabx-ray diffractionG, I, J, K——
5LGJThe crystal structure of IgE Fc mutant - P333Cx-ray diffractionA, BNAG, BMA, MAN, SO46 (best 0.77)
5LGJThe crystal structure of IgE Fc mutant - P333Cx-ray diffractionA, BNAG, BMA, MAN, SO4—
5LGKCrystal structure of the human IgE-Fc bound to its B cell receptor derCD23x-ray diffractionA, B, C, DNAG, BMA20 (best 0.79)
5LGKCrystal structure of the human IgE-Fc bound to its B cell receptor DERCD23x-ray diffractionA, B, C, DNAG, BMA—
5MOICrystal structure of human IgE-Fc epsilon 3-4x-ray diffractionA, B, C, D, E, FNAG, BMA, MAN, PO411 (best 0.81)
5MOICrystal structure of human IgE-Fc epsilon 3-4x-ray diffractionA, B, C, D, E, FNAG, BMA, MAN, PO4—
5MOJCrystal structure of IgE-Fc epsilon 3-4x-ray diffractionA, BNAG, BMA, MAN, SO45 (best 0.57)
5MOJCrystal structure of IgE-Fc epsilon 3-4x-ray diffractionA, BNAG, MAN, BMA, SO4—
5MOKCrystal structure of human IgE-Fc epsilon 3-4x-ray diffractionA, B, C, DNAG, BMA, MAN—
5MOKCrystal structure of human IgE-Fc epsilon 3-4x-ray diffractionA, B, C, DNAG, BMA, MAN—
5MOLHuman IgE-Fc crystal structurex-ray diffractionA, BNAG, BMA, MAN, AE312 (best 0.67)
5MOLHuman IgE-Fc crystal structurex-ray diffractionA, BNAG, BMA, MAN, AE3—
5NQWIgE-Fc in complex with single domain antibody 026x-ray diffractionA, BNAG, BMA, MAN—
5NQWIgE-Fc in complex with single domain antibody 026x-ray diffractionA, BNAG, BMA, MAN—
6EYOStructure of extended IgE-Fc in complex with two anti-IgE Fabsx-ray diffractionA, BNAG, BMA, MAN8 (best 0.76)
6EYOStructure of extended IgE-Fc in complex with two anti-IgE fabsx-ray diffractionA, BNAG, BMA, MAN—
6UQRComplex of IgE and Ligelizumabx-ray diffractionB, DNAG, BMA, MAN8 (best 0.63)
6UQRComplex of IgE and ligelizumabx-ray diffractionB, DNAG, BMA, MAN—
7MXIIgE-Fc in complex with DARPins E2_79 and E3_53x-ray diffractionA, BNAG, BMA, FUC12 (best 0.59)
7MXIIgE-Fc in complex with darpins E2_79 and E3_53x-ray diffractionA, BNAG, BMA, FUC—
7SHTStructure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variantelectron microscopyB, DNAG, MAN11 (best 0.81)
7SHTStructure of a partially disrupted IgE high affinity receptor complex bound to an omalizumab variantelectron microscopyB, DNAG, MAN—
7SHUIgE-Fc in complex with omalizumab variant C02x-ray diffractionB, ANAG, BMA, PO46 (best 0.66)
7SHUIgE-Fc in complex with omalizumab variant C02x-ray diffractionB, ANAG, BMA, PO4—
7SHYIgE-Fc in complex with omalizumab scFvx-ray diffractionA, G, H, BNAG, BMA, MAN, FUC13 (best 0.69)
7SHYIgE-Fc in complex with omalizumab scfvx-ray diffractionA, G, H, BNAG, BMA, MAN, FUC—
7SHZIgE-Fc in complex with HAEx-ray diffractionB, A, H, GNAG, BMA, MAN11 (best 0.68)
7SHZIgE-Fc in complex with haex-ray diffractionB, A, H, GNAG, BMA, MAN—

6 records more on the page itself.

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 35 records
  • BMA · beta-D-mannopyranose · in 33 records
  • MAN · alpha-D-mannopyranose · in 28 records
  • SO4 · Sulfate ion · in 5 records
  • FUC · alpha-L-fucopyranose · in 4 records
  • PO4 · Phosphate ion · in 4 records
  • AE3 · 2-(2-ethoxyethoxy)ethanol · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.